ABI

Ambri (ABI)

Stock Code

ABI

Stock Exchange

ax

Ambri (ABI) is a biotechnology development company. Its principal activities include integrating biotechnology, nanotechnology and electronics to make biosensors for medical and industrial applications. ABI listed on ASX on 16 June, 2000. AMBRI is engaged in the development of a biosensor platform incorporating AMBRI’s Ion Channel Switch (ICS) Technology to be used in the products for the human point-of-care diagnostic market. The ABI’s Ion Channel Switch (ICS) Technology is a patented, self-assembling synthetic bio-membrane, which is one of the first true 'bio nano' devices in the world.

Syndicate content

Recommended Websites